Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01216319
Other study ID # 09-009
Secondary ID
Status Completed
Phase N/A
First received October 5, 2010
Last updated April 30, 2015
Start date September 2011
Est. completion date April 2014

Study information

Verified date April 2015
Source Cook
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Patients with a desire for nipple reconstruction following breast cancer and breast reconstruction will receive a surgical procedure to reconstruct one or both nipples utilizing the COOK(r) Biodesign(r) Nipple Reconstruction Cylinder.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date April 2014
Est. primary completion date April 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patient presents with a history of breast cancer, having previously completed either uni- or bi-lateral breast removal and reconstruction.

- Patient presents with a desire to obtain nipple reconstruction

- Patient is at least 18 years of age

- And other inclusion criteria

Exclusion Criteria:

- Patient is not medically fit enough for surgery under local anesthesia

- Patient is currently smoking, using tobacco products, or nicotine products (i.e. patch, gum, or nasal spray)

- Patient is pregnant, breastfeeding or planning further pregnancy during the study period

- Patient has physical allergies or cultural objections to the receipt of porcine products

- And other exclusion criteria

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Intervention

Device:
Nipple reconstruction
Biodesign® Nipple Reconstruction Cylinder

Locations

Country Name City State
United States Mercy Medical Center Baltimore Maryland
United States Park Meadows Cosmetic Surgery Lone Tree Colorado
United States Sanford Clinic Plastic and Reconstructive Surgery Sioux Falls South Dakota
United States Stanford University School of Medicine Stanford California

Sponsors (1)

Lead Sponsor Collaborator
Cook

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percent Nipple Projection at 12 Months Compared to Baseline (1 Week Post-procedure) 12 months No
Secondary Rate of Patient Satisfaction Patient satisfaction is defined as patient would recommend the nipple reconstruction operation to others. 12 months No
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A